EV/EBITDA:
-11.52+0.13(+1.12%)Summary
- As of today, APGE EV/EBITDA is -11.52, with a rise of +0.13 (+1.12%) during the most recent trading session on October 24, 2025.
- Over the past year, APGE EV/EBITDA has increased by +2.20 (+16.03%).
- APGE EV/EBITDA is now -129.48% below its all-time high of -5.02.
Performance
APGE EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
APGE EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | +1.1% | -1.1% | -0.9% |
| 1M1 Month | -73.2% | +73.4% | +38.8% |
| 3M3 Months | -56.5% | +56.7% | +28.1% |
| 6M6 Months | -67.4% | +87.4% | +43.9% |
| YTDYTD | -14.2% | +42.4% | +17.7% |
| 1Y1 Year | +16.0% | +27.4% | +2.6% |
| 5Y5 Years | - | - | - |
APGE EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | -6.45 | -78.6% | -12.43 | +7.3% |
| 3M | 3-Month | -5.81 | -98.3% | -12.43 | +7.3% |
| 6M | 6-Month | -5.81 | -98.3% | -12.43 | +7.3% |
| 1Y | 1-Year | -5.02 | -129.5% | -16.65 | +30.8% |
| 3Y | 3-Year | -5.02 | -129.5% | -38.03 | +69.7% |
| 5Y | 5-Year | -5.02 | -129.5% | -38.03 | +69.7% |
| All-Time | All-Time | -5.02 | -129.5% | -38.03 | +69.7% |
APGE EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -11.52(-14.2%) |
| Date | Value |
|---|---|
| 2024 | -10.09(+2.5%) |
| 2023 | -10.35 |
FAQ
- What is Apogee Therapeutics, Inc. EV/EBITDA?
- What is the all-time high EV/EBITDA for Apogee Therapeutics, Inc.?
- What is APGE EV/EBITDA year-to-date change?
- What is Apogee Therapeutics, Inc. EV/EBITDA year-on-year change?
What is Apogee Therapeutics, Inc. EV/EBITDA?
The current EV/EBITDA of APGE is -11.52
What is the all-time high EV/EBITDA for Apogee Therapeutics, Inc.?
Apogee Therapeutics, Inc. all-time high EV/EBITDA is -5.02
What is APGE EV/EBITDA year-to-date change?
Apogee Therapeutics, Inc. EV/EBITDA has changed by -1.43 (-14.17%) since the beginning of the year
What is Apogee Therapeutics, Inc. EV/EBITDA year-on-year change?
Over the past year, APGE EV/EBITDA has changed by +2.20 (+16.03%)